Naturalistic Follow-up after a Trial of Medications for Opioid Use Disorder: Medication Status, Opioid Use, and Relapse

This report examined naturalistic opioid use outcomes and utilization of medications for opioid use disorder (MOUD) 36 weeks post-randomization in the National Drug Abuse Treatment Clinical Trials Network (CTN) Extended-Release Naltrexone (XR-NTX) versus Buprenorphine-Naloxone (BUP-NX) for Opioid Treatment trial (CTN-0051, X:BOT).

Source: Journal of Substance Abuse Treatment - April 30, 2021 Category: Addiction Authors: Miranda G. Greiner, Matisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, Martina Pavlicova, Aimee N.C. Campbell, Patricia Novo, Marc Fishman, Joshua D. Lee, John Rotrosen, Edward V. Nunes Source Type: research